Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Dec 19, 2006
Engages Burrill to progress out-licensing
Dec 05, 2006
Partnering Update Presentation
Nov 03, 2006
Appendix 3B
Nov 03, 2006
Raises $1.6million
Oct 31, 2006
Commitments Test Entity - Third Quarter Report
Oct 23, 2006
Letter to shareholders re SPP extension
Oct 20, 2006
Preclinical results show cancer regression
Oct 17, 2006
Extends SPP
Oct 16, 2006
NNZ 2591 positive memory loss reversal results
Sep 29, 2006
Notice under section 708A(5)(e) of the Corporations Act
1
2
3
4
5
Next
